Drinking at least 3-4 cups of coffee daily can reduce the risk of head and neck cancer – which is increasing across the world ...

According to Tshwane MMC for Health, Tshegofatso Mashabela, current low vaccination rates have contributed significantly to the outbreak.

Background: Nasopharyngeal carcinoma (NPC) is a type of malignant tumors commonly found in Southeast Asia and China, with insidious onset and clinical symptoms. N6-methyladenosine (m6A) modification ...

New research has shown that screening or testing for past Epstein-Barr virus infections can help find people at a higher risk ...

Background: Nasopharyngeal carcinoma (NPC) is a highly invasive malignant tumor. Recurrence and distant metastasis represent the primary causes of treatment failure. This study aimed to identify ...

Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer. Toripalimab, a New Biological ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India. Toripalimab, a PD-1 inhibitor, provides a new treatment option for this rare ...

“The launch of Toripalimab is a significant milestone for patients diagnosed with nasopharyngeal carcinoma (NPC) in India. NPC is a rare form of head and neck cancer. However, the prognosis of ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...

The stock climbed after the company announced the launch of Toripalimab in India. Toripalimab (Loqtorzi) is a drug used to treat certain types of nasopharyngeal carcinoma (NPC), a type of head and ...

Objective The role of cigarette smoking as an independent risk factor for patients with nasopharyngeal carcinoma (NPC) is controversial. We attempted to provide evidence of a reliable association ...